CA9hu-1

N/A

Report date: 2023/02/01 18:04:34

Base Information

Drug NameCA9hu-1
Drug Alias NameHumanized monoclonal antibody to human carbonic anhydrase IXhu-CA91CA9hu-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Carbonic anhydrase IX
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsTriple Negative Breast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMabpro AS
China Registration ClassN/A

Develop Information

Active CompaniesMabpro AS
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsTriple Negative Breast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A